COMPANY PROFILE // THE 014 REPORT
Universe Pharmaceuticals INC
UPC (Nasdaq)
Assembled from 2 government sources in 1.7 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberNT 20-F filed on 2025-01-27: notice that a periodic report would be late.
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Universe Pharmaceuticals INC is an SEC-registered company in pharmaceutical preparations, incorporated in China, based in Ji'An, Jiangxi, China; listed as UPC (Nasdaq).[source] It reported revenue of $17.86 billion for the fiscal year ended 2025-09-30.[source] It has filed 29 documents with the SEC in the last 12 months; the latest is a EFFECT, filed 2026-10-09.[source] Its largest institutional holders on 13F filings are UBS Group AG, OSAIC HOLDINGS, INC., HRT FINANCIAL LP (as of 2026-06-30).[source] Seraphix flags 1 item from these records: NT 20-F filed on 2025-01-27.[source]
- red0
- amber1
- info0
- UBS Group AG$88K
- OSAIC HOLDINGS, INC.$38K
- HRT FINANCIAL LP$103
- Caitong International Asset Management Co., Ltd$73
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Lai Gang · Chief Executive Officer (Director,Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- Liu Baochang · Chief Operating Officer (Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- Yang Lin (Lydia) · Chief Financial Officer (Director,Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- Pang Jiawen · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
- Yu Yongping · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
- Zheng Ding · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001809616 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | 265 JINGJIU AVENUE, JI'AN, JIANGXI, F4, 343100 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-01-28 · in 69 days · Next 20-F due (period ended 2026-09-30; Non-accelerated filer<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-10-09 filing EFFECT · SEC EDGAR
- 2026-10-06 filing 6-K · SEC EDGAR
- 2026-09-29 filing F-3 · SEC EDGAR
- 2026-09-03 filing 6-K/A · SEC EDGAR
- 2026-09-01 filing 6-K · SEC EDGAR
- 2026-07-31 filing 6-K · SEC EDGAR
- 2026-07-29 filing 6-K · SEC EDGAR
- 2026-06-26 filing 6-K · SEC EDGAR
- 2026-05-21 filing SCHEDULE 13D · SEC EDGAR
- 2026-05-14 filing 6-K · SEC EDGAR
- 2026-04-16 filing 6-K · SEC EDGAR
- 2026-03-18 insider First Form 3/4/5 on record for Lai Gang (Chief Executive Officer) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Liu Baochang (Chief Operating Officer) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Yang Lin (Lydia) (Chief Financial Officer) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Pang Jiawen (Director) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Yu Yongping (Director) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Zheng Ding (Director) · SEC Forms 3/4/5
- 2026-02-11 filing 6-K · SEC EDGAR
- 2026-01-29 filing Annual report (20-F) · SEC EDGAR
- 2025-09-03 filing 6-K · SEC EDGAR
- 2025-08-26 filing 6-K · SEC EDGAR
- 2025-07-29 filing 6-K · SEC EDGAR
- 2025-07-03 filing 6-K · SEC EDGAR
- 2025-04-29 filing Annual report (20-F) · SEC EDGAR
- 2025-03-20 filing 6-K · SEC EDGAR
- 2025-03-11 filing 6-K · SEC EDGAR
- 2025-03-03 filing 6-K · SEC EDGAR
- 2025-02-25 filing 6-K · SEC EDGAR
- 2025-02-20 filing 6-K · SEC EDGAR
- 2025-02-18 filing 6-K · SEC EDGAR
73 earlier entries
- 2025-02-11 filing 6-K
- 2025-02-03 filing 6-K
- 2025-01-30 filing 6-K
- 2025-01-27 filing NT 20-F
- 2024-12-12 filing 6-K
- 2024-12-09 filing 424B5
- 2024-11-13 filing 6-K
- 2024-11-01 filing 6-K
- 2024-10-10 filing 6-K
- 2024-09-27 filing 6-K
- 2024-09-20 filing 6-K
- 2024-09-03 filing 6-K
- 2024-07-18 filing 6-K
- 2024-06-25 filing 424B4
- 2024-06-07 filing EFFECT
- 2024-06-05 filing CORRESP
- 2024-05-14 filing CORRESP
- 2024-05-14 filing F-1/A
- 2024-05-08 filing UPLOAD
- 2024-04-24 filing F-1
- 2024-02-07 filing 6-K
- 2024-01-30 filing Annual report (20-F)
- 2023-08-31 filing 6-K
- 2023-08-16 filing 6-K
- 2023-08-04 filing 6-K
- 2023-07-27 filing 6-K
- 2023-07-05 filing 6-K
- 2023-05-24 filing 6-K
- 2023-05-05 filing 6-K
- 2023-02-10 filing Annual report (20-F)
- 2023-01-30 filing NT 20-F
- 2022-11-15 filing EFFECT
- 2022-11-14 filing 6-K
- 2022-10-27 filing F-3
- 2022-09-28 filing 6-K
- 2022-08-29 filing 6-K
- 2022-08-16 filing 6-K
- 2022-07-19 filing 6-K
- 2022-01-31 filing 6-K
- 2022-01-31 filing Annual report (20-F)
- 2021-12-15 filing 6-K
- 2021-12-10 filing 6-K
- 2021-12-09 filing 6-K
- 2021-08-02 filing 6-K
- 2021-03-31 filing 6-K
- 2021-03-25 filing 6-K
- 2021-03-24 filing 424B4
- 2021-03-22 filing EFFECT
- 2021-03-22 filing CERT
- 2021-03-17 filing CORRESP
- 2021-03-17 filing CORRESP
- 2021-03-17 filing 8-A12B
- 2021-03-10 filing CORRESP
- 2021-03-10 filing F-1/A
- 2021-03-02 filing UPLOAD
- 2021-03-01 filing FWP
- 2021-03-01 filing FWP
- 2021-02-24 filing F-1/A
- 2020-12-10 filing FWP
- 2020-12-02 filing CORRESP
- 2020-12-02 filing F-1/A
- 2020-11-19 filing UPLOAD
- 2020-11-17 filing CORRESP
- 2020-11-17 filing F-1/A
- 2020-09-23 filing FWP
- 2020-09-01 filing UPLOAD
- 2020-08-17 filing CORRESP
- 2020-08-17 filing F-1
- 2020-06-24 filing UPLOAD
- 2020-06-12 filing DRSLTR
- 2020-06-12 filing DRS/A
- 2020-05-20 filing UPLOAD
- 2020-04-24 filing DRS
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-09 (older) EFFECT filed
- 2026-10-06 (older) 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-09-29 (older) F-3 filed (REGISTRATION STATEMENT)
- 2026-09-03 (older) 6-K/A filed (AMENDMENT NO. 1 TO FORM 6-K)
- 2026-09-01 (older) 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-07-31 (older) 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-07-29 (older) 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-06-26 (older) 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:UPC The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1809616 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | UPC / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | G9442G138 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001809616 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-09-30) | $17,858,732,000 | 2025-09-30 | 20-F, XBRL Revenues | as filed | 2026-11-20 10:13 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-09-30) | -$3,672,055,000 | 2025-09-30 | 20-F, XBRL NetIncomeLoss | as filed | 2026-11-20 10:13 UTC | Report an error |
| Total assets (at 2025-09-30) | $69,303,440,000 | 2025-09-30 | 20-F, XBRL Assets | as filed | 2026-11-20 10:13 UTC | Report an error |
| Stockholders' equity (at 2025-09-30) | $56,129,510,000 | 2025-09-30 | 20-F, XBRL StockholdersEquity | as filed | 2026-11-20 10:13 UTC | Report an error |
| Cash and cash equivalents (at 2025-09-30) | $33,592,025,000 | 2025-09-30 | 20-F, XBRL CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | as filed | 2026-11-20 10:13 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | other | 2026-10-09 | SEC EDGAR company profile | as filed | 2026-11-20 10:13 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-10-09 | SEC EDGAR company profile | as filed | 2026-11-20 10:13 UTC | Report an error |
| State of incorporation | F4 | 2026-10-09 | SEC EDGAR company profile | as filed | 2026-11-20 10:13 UTC | Report an error |
| Fiscal year end (MMDD) | 0930 | 2026-10-09 | SEC EDGAR company profile | as filed | 2026-11-20 10:13 UTC | Report an error |
| Business address | 265 JINGJIU AVENUE, JINGGANGSHAN ECON. AND TECH. DEV. ZONE, JI'AN, JIANGXI, F4, 343100 | 2026-10-09 | SEC EDGAR company profile | as filed | 2026-11-20 10:13 UTC | Report an error |
| Exchanges | Nasdaq | 2026-10-09 | SEC EDGAR company profile | as filed | 2026-11-20 10:13 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-09-30) | -$5,052,319,000 | 2025-09-30 | 20-F, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 10:13 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-09-30) | $266,771,000 | 2025-09-30 | 20-F, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 10:13 UTC | Report an error |
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-09 Filing EFFECT filed
- 2026-10-06 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-09-29 Filing F-3 filed (REGISTRATION STATEMENT)
- 2026-09-03 Filing 6-K/A filed (AMENDMENT NO. 1 TO FORM 6-K)
- 2026-09-01 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-07-31 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-07-29 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-06-26 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-05-14 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-04-16 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-02-11 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-01-29 Filing 20-F filed (ANNUAL REPORT)
- 2025-09-03 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-08-26 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-07-29 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-07-03 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-04-29 Filing 20-F filed (ANNUAL REPORT)
- 2025-03-20 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-03-11 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-03-03 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-02-25 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-02-20 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-02-18 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2025-02-11 Filing 6-K filed (CURRENT REPORT)
- 2025-02-03 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | UBS Group AG | $87,639 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:13 UTC | Report an error |
| 2 | OSAIC HOLDINGS, INC. | $37,649 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:13 UTC | Report an error |
| 3 | HRT FINANCIAL LP | $103 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:13 UTC | Report an error |
| 4 | Caitong International Asset Management Co., Ltd | $73 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:13 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1809616.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001809616. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.